FDA Approves KYGEVVI®, the First and Only Treatment for Thymidine Kinase 2 deficiency (TK2d)

Medical Educational Resource

We're accelerating the delivery of treatments and cures.

Updates in Spinal-Bulbar Muscular Atrophy

Activity Snapshot

Activity Type: 
On-Demand Webinar
Release Date: 
Monday, August 19, 2024

Faculty

Christopher Grunseich, MD
Investigator

NINDS, National Institutes of Health, Bethesda, MD

Activity Overview: 

Featuring Christopher Grunseich, MD, of National Institute of Neurological Disorders and Stroke (NINDS), this webinar will include a disease overview and discussion of multidisciplinary management strategies, the importance of genetic testing, and incorporating recent clinical advancements into patient care.

Download Clinician Flashcard